Late-Breaking Clinical Trials | Coronary CABG / PCI

Sunday, March 10, 2024

2:15 PM – 3:15 PM ET

Moderator(s)

Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom
Jonathan Hill, MD

Consultant Cardiologist
Royal Brompton and Harefield Hospitals
LONDON, England, United Kingdom

Panel Discussant(s)

H. Vernon Anderson, MD

Professor of Medicine
University of Texas Health Science Center
McGovern Medical School
Houston, Texas, United States
Subhash Banerjee, MD

Chief of Cardiovascular Research & Innovation
Baylor Scott & White Heart and Vascular Institute, Dallas, TX
Dallas, Texas, United States
Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI

Professor of Medicine
New York University School of Medicine
New York University School of Medicine
New York, New York, United States
Hector Garcia-Garcia, MD, PhD

Director of Invasive Imaging Core Laboratory
MedStar Washington Hospital Center
Washington, District of Columbia, United States
William Gray, MD, FSCAI

System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
Main Line Health
Wynnewood, Pennsylvania, United States
Thomas MacGillivray, MD

Physician Executive Director and Chair, Cardiac Surgery
MedStar Health, MedStar Washington Hospital Center
Washington, District of Columbia, United States
EM

Eugene McFadden, MD

Cardiologist
Cork University Hospital
Cork, Cork, Ireland
Angela McInerney, MD

Interventional Cardiologist
University Hospital Galway, Ireland , Clare, Ireland
Natalia Pinilla, MD, PhD

Assistant Professor / Interventional Cardiologist
McMaster University
Burlington, Ontario, Canada

Disclosure(s):

Rasha Al-Lamee, MA, MD, PhD: Medtronic Vascular: Honoraria (Ongoing)

Jonathan M. Hill, MD: No relationships to disclose

H. Vernon Anderson, MD: No relationships to disclose

Subhash Banerjee, MD: No relationships to disclose

Thomas E. MacGillivray, MD: No relationships to disclose

Eugene P. McFadden, MD: No relationships to disclose

Angela E. McInerney, MD: No relationships to disclose

Natalia Pinilla, MD, PhD: No relationships to disclose

Presentations:

2:15 PM – 2:23 PM ET

The Association of Socioeconomic Status with Procedural Management and Mortality After Percutaneous Coronary Intervention: An Observational Study from the Pan-London PCI Registry
Speaker: Krishnaraj S. Rathod, MBBS, BMedSci (Hons), MRCP (UK), PhD, QDip, FESC – Bart Heart Centre, St. Bartholomew's Hospital
2:23 PM – 2:27 PM ET

Panel Discussion
2:27 PM – 2:35 PM ET

Computed Tomography Cardiac Angiography Prior to Invasive Coronary Angiography in Patients with Previous Bypass Surgery: Patient-Related Outcomes, Imaging Resource Utilisation, and Long-Term Cardiac Events from the BYPASS-CTCA Trial
Speaker: Matthew Kelham, MD – St Bartholomew's Hospital, London, UK
2:35 PM – 2:39 PM ET

Panel Discussion
2:39 PM – 2:47 PM ET

The Safe Surveillance of Percutaneous Coronary Intervention Under Mechanical Circulatory Support with the Saranas Early Bird Bleeding Monitoring System (SAFE-MCS) Study
Speaker: Babar Basir, DO – Henry Ford Hospital
2:47 PM – 2:51 PM ET

Panel Discussion
2:51 PM – 2:59 PM ET

Time-Dependent Outcomes with the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-Up: Final Report from the ABSORB Trial Program
Speaker: David Power, MD – Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai New York, New York
2:59 PM – 3:03 PM ET

Panel Discussion
3:03 PM – 3:11 PM ET

Immediate Versus Staged Complete Revascularization in Patients Presenting with Acute Coronary Syndrome and Multivessel Coronary Disease: 2-Year Follow-Up of the Multicentre Randomized Controlled BIOVASC Trial
Speaker: Robert Diletti, MD
3:11 PM – 3:15 PM ET

Panel Discussion
3:15 PM ET

Adjourn